<DOC>
	<DOCNO>NCT00112203</DOCNO>
	<brief_summary>Itopride compound already market Japan country Eastern Europe name Ganaton . It use treat symptom functional dyspepsia . Patients suffer condition difficulty digest food . Patients feel full eating ; bloat stomach pain . The goal study see itopride help relieve symptom functional dyspepsia long-term basis .</brief_summary>
	<brief_title>Long-Term Safety Efficacy Itopride Hydrochloride ( HCl ) Patients Suffering From Functional Dyspepsia</brief_title>
	<detailed_description>All patient complete study ITOFD04-03 offer continue treat itopride period one year duration . A target 300 patient follow 6 month . Of , target 100 patient keep treatment additional 6 month . Patients need come clinic evaluation every 8 week trial . Evaluations do visit include : lab test , evaluation heartburn condition , questionnaire need complete patient see drug helpful relieving symptom .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>Patients must complete 8 week doubleblind study ITOFD0403 Female patient must pregnant ( must negative serum pregnancy test ) Patients newly occur medical condition exclusion criterion ITOFD0403 study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Abdominal Symptom Relief</keyword>
	<keyword>Fullness</keyword>
	<keyword>Bloating</keyword>
	<keyword>Indigestion</keyword>
	<keyword>Functional dyspepsia</keyword>
</DOC>